drugset / Trial / NCT00412776
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the safety and efficacy of Proxinium plus best supportive care with best supportive care only for patients with squamous cell head and neck cancer.
Timeline
- Start
- 2005-12
- Primary completion
- 2008-04
- Completion
- 2008-04
Outcome
Outcome not reported
Stopped: “Corporate reasons unrelated to safety and efficacy”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Proxinium | Protein / enzyme biologic | 700 ug | Other |